PA PER Cybersecurity for Pharmaceutical Enterprisesakamai.com | 1 Introduction Pharmaceutical companies have long been targets of cyberattacks for their extremely valuable intellectual property (IP) and the astronomical costs associated with disruption or downtime. Since the onset of the pandemic, their profile has grown even more attractive to cybercriminals. Many of the largest pharmaceutical companies have been the targets of attackers seeking vaccine-related IP since 2020, but it’s not only the big players that are under attack. Pharma companies large and small are being targeted, as work-from-home endpoints, migration from on- premises and legacy systems to cloud and hybrid cloud solutions, and the increased exchange of data through patient and healthcare provider

Join for free to read